18 research outputs found

    Presentación de diagnóstico financiero y análisis bursátil Corficolombiana S.A

    Get PDF
    Corficolombiana S.A es el inversionista líder en la organización, gestión y dirección de empresas y proyectos en Colombia. Esto ha hecho que se posiciones en una de las corporaciones más importes de nuestro país, a nivel económico en el contexto nacional e internacional; permitiendo la generación de empleo, desarrollo económico, y nuevas oportunidades de crecimiento en sectores claves de la economía. Constantemente realiza actividades que le permiten mejorar estando a la vanguardia de los resultados y actividades dentro del sector, acciones como inversiones en nuevos proyectos, políticas de inversión responsable, inversiones sostenibles, políticas de compra sostenibles, hacen de corficolombiana S.A la corporación más confiable del sector. Gracias a su grupo corporativo, su equipo de trabajo y profesionalismo del mismo, ha venido desarrollando diferentes diagnósticos financieros y análisis de sus diferentes fuentes de inversión, apalancamiento y evolución desde su creación hasta la fecha actual, que le permite mejorar día a día y corregir las posibles falencias que presente. Su cotización en la bolsa de valores y crecimiento económico a largo plazo es uno de los más altos y confiables.Corficolombiana S.A is the leading investor in the organization, management and direction of companies and projects in Colombia. This has made it one of the most important corporations in our country, economically in the national and international context; allowing the generation of employment, economic development, and new growth opportunities in key sectors of the economy. It constantly carries out activities that allow it to improve by being at the forefront of results and activities within the sector, actions such as investments in new projects, responsible investment policies, sustainable investments, sustainable purchasing policies, make corficolombiana the most reliable corporation in the sector. Thanks to its corporate group, its work team and its professionalism, it has been developing different financial diagnoses and analyzes of its different sources of investment, leverage and evolution since its creation to the current date, which allows it to improve day by day and correct the possible shortcomings it presents. Its stock market price and long-term economic growth is one of the highest and most reliable

    Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial

    No full text

    Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome

    No full text

    Alirocumab and cardiovascular outcomes after acute coronary syndrome

    No full text
    BACKGROUN

    Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial

    No full text

    Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

    No full text
    BACKGROUN

    Alirocumab in patients with polyvascular disease and recent acute coronary syndrome ODYSSEY OUTCOMES trial

    No full text

    Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes

    No full text
    10.1161/CIRCULATIONAHA.119.042551CIRCULATION140191578-158

    Alirocumab reduces total hospitalizations and increases days alive and out of hospital in the ODYSSEY OUTCOMES trial

    No full text

    Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events The ODYSSEY OUTCOMES Trial

    No full text
    corecore